Specific binding sites for 3,3′-diiodo-l-thyronine (3,3′-T2) in rat liver mitochondria  by Lanni, Antonia et al.
FEBS Letters 351 (1994) 237-240 




(3,3'-T2) in rat liver 
Antonia Lanni a, Maria Moreno a, Claus Horst b, Assunta Lombardi a, Fernando Goglia a'* 
aDipartimento di Fisiologia Generale d Ambientale, Universitd i NapolL 1-80134 NapolL Italy 
bMarion Merrell Dow Research Institute, Henning Berlin R&D, D-12067 Berlin, Germany 
Received 2 July 1994; revised version received 18 July 1994 
Abstract Specific binding sites for 3,3'-T2 can be detected in swollen and osmotically treated mitochondria (OTM) from normal and hypothyroid 
rat liver. In hypothyroid animals, maximal values of binding were obtained at 0°C and 20°C while values were lower at 37°C and no specific binding 
could be observed at 60°C. Binding was maximal at pH 6.4 and the mean values for the apparent association constant (Ka) and the binding capacity 
were on average 0.5 x 108 M -~ and 2.4 pmol/mg mitochondrial protein, respectively. No differences were observed between ormal and hypothyroid 
rats with the exception of the capacity that was higher in normal animals (5.5 pmol/mg mitochondrial protein). The specificity of 3,3'-T2 binding, 
examined in competition studies, followed this order: 3,3'-T2 > 3,5-T 2 > rT3. The other iodothyronines (3',5'-T2, T3, T4, 3-T~, 3'-T~, 3,5-Diac and 
3,3'-Diac) showed only a small competition or none at all. 
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1. Introduction 
Thyroid hormones are involved in the regulation of growth, 
development and cell differentiation i  many organisms and, 
in addition, they have notable effects on respiration and energy 
metabolism. In this context he question of a direct action of 
the hormones on mitochondria is so far unresolved. In fact, in 
spite of several reports showing rapid effects of tri iodothyron- 
ine (T3) on mitochondria, the occurrence and the physiological 
significance of these effects is a long standing controversial 
issue of thyroid hormone action. In recent years, however, 
several reports have shown that two diiodothyronines (3,3'-T2 
and 3,5-T2), under certain conditions, are the only iodothyron- 
ines which rapidly stimulate in vivo and in vitro mitochondrial 
respiration or cytochrome oxidase (COX) activity [1-6]. At the 
moment, the physiological significance of these effects is not 
clear and no insight into the mechanism by which diiodothy- 
ronines stimulate mitochondrial energy metabolism is availa- 
ble. As diiodothyronines have a rapid effect in vitro on rat liver 
mitochondrial COX activity these results should be the conse- 
quence of a direct interaction of diiodothyronines with specific 
mitochondrial binding sites. In this study, because we observed 
that the effect of 3,3'-T2 could not be shown when added to 
intact mitochondria but was evident when added to isolated 
swollen and osmotically treated mitochondria (OTM), we have 
tried to show the presence of  specific binding sites for 3,3'-T2 
in OTM from the liver of normal and hypothyroid rats. 
Hypothyroidism was induced by propylthiouracil (PTU) ad- 
ministration for two reasons: (a) PTU is an inhibitor of some 
deiodinating enzymes [7] and this allows us to inhibit a possible 
pathway ofT2 metabolism; (b) after three weeks o fPTU admin- 
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istration the presence of endogenous iodothyronines i  strongly 
reduced [l] and the endogenous occupation of the binding sites 
should consequently be lowered. 
2. Materials and methods 
2.1. Materials 
3,[3'-125I]T2 (3000 pCi/gg); 3,5-T2; 3,3'-T2; 3',5'-T2; T4; T3; rT3; 3,5- 
Diac; 3,3'-Diac; 3'-Tt; 3-T~ were from MMDRI, Henning Berlin R&D 
(Berlin, Germany) and > 99.5% pure. 
2.2. Animals 
Male Wistar rats weighing approximately 300 g were used through- 
out the study. In one group of animals hypothyroidism was induced by 
the addition of 0.1% (w/v) PTU to the drinking water for 3 weeks. 
At the end of treatment, both normal and hypothyroid rats were 
sacrificed by decapitation. Liver was quickly removed and placed in the 
appropriate medium for mitochondria separation. 
2.3. Preparation of mitochondrial fraction 
Liver mitochondria were isolated at 3000 x g according to the proce- 
dure described in [8]. The mitochondrial pellet was further fractionated 
using an osmotic shock according to a slightly adapted method previ- 
ously described [9]. Briefly, 3 mg of mitochondrial protein were swollen 
for 30 min at 37°C in 1 ml of 0.1 M potassium phosphate buffer (pH 
7.4) to disrupt and partially eliminate the outer membrane and also 
some cytoplasmic contaminants [10,11]. After collection, swollen mito- 
chondria were treated by l0 min incubation in a hypotonic phosphate 
buffer (8 mM; pH 7.4). Osmotically treated mitochondria (OTM) were 
spun down by centrifugation and resuspended in isosmotic buffer to 
give a final protein concentration of 10 mg/ml, determined by the 
method of Hartree [12] using bovine serum albumine (BSA) as a stand- 
ard. 
Published procedures were used to measure the activities of uricase 
[13], glucose-6-phosphatase [14], acid-phosphatase [15] and succinic 
dehydrogenase [16]. 
2.4. Cytochrome oxidase activity 
Aliquots of OTM (2.5 mg/ml) were incubated at 0°C with 3,3'-T 2 in 
a final concentration of 10 -6 M. After the addition of 3,3'-T2, the 
mixture was blended in a vortex and incubated for 30 min before the 
cytochrome oxidase activity assay. 
Cytochrome oxidase activity in the OTM was determined polarogra- 
phically at 25°C using a Clark oxygen electrode according to the 
method of Grav et al. as modified by Aulie and Grav [17,18]. Briefly: 
in 1,5 mt of reaction medium containing 30 pM cytochrome c,4/IM 
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rotenone, 0.5 mM dinitrophenol, 10 mM Na malonate, 75 mM HEPES 
buffer, pH 7.4. Cytochrome oxidase activity was measured as the differ- 
ence between the rate of oxygen consumption observed after the addi- 
tion of substrate (4 mM sodium ascorbate with 0.3 mM N,N,N',N'.- 
tetramethyl-p-phenylene-diamine (TMPD)) and mitochondria (50/~g of 
protein), and the rate of oxygen consumption observed after the addi- 
tion of substrate alone, in order to take into account the auto-oxidation 
of ascorbate. 
2.5. Incubation procedure [br binding studies 
Incubations with 3,[3'-tzSI]T2 (T*) (3000/ICi/pg 3,3'-T2, 0.05 pg/ml) 
were carried out for 30 min at 0°C in 1 ml of buffer using 10-100 nmol/1 
T~'and OTM (0.7 1.4 mg of protein). T~'bound to OTM was separated 
from free T* by centrifugation. Residual unbound or loosely bound -T* 
was removed from mitochondria by three washes in the presence of 
0.5% bovine serum albumine, as previously described [9]. Non-specific 
binding was determined in parallel incubations with a 1000-fold excess 
of unlabelled 3,3'-T 2. K, and capacity were calculated according 
to Scatchard [19]. The specificity of 3,3'-T 2 binding to mitochondria 
was examined in competition studies using one low concentration of
3,[3'-~25I]T2 and increasing concentrations of cold analogues. Radioac- 
tivity was measured in a Beckman 4000 spectrometer with 70% of 
efficiency. 
Values are expressed as mean ± S.E.M. Statistically significant differ- 
ences were examined using Student's t-test. 
3. Results 
3.1. Enzymatic profile of the swollen mitochondrial preparation 
Due to the low gravitational force used to obtain mitochon- 
dr±a, the mitochondrial  fractions utilized in our experiments 
were almost pure. In fact, both in intact mitochondria nd in 
OTM the values were below the detection limit for uricase and 
glucose-6-phosphatase, while acid phosphatase activity was 
0.65 ¢tg P Jmg prote in-min and 0.4/.tg Pi/mg protein, min for 
intact mitochondr ia nd OTM, respectively. (These activities 
represent 5% and 3% of the mean values in a lysosomal fraction 
[8]. Succinic dehydrogenase activity, on the other hand, was 
0.088 ¢tmol/min.mg protein in the homogenate, 0.28 /.tmol/ 
min .mg protein in intact mitochondria and 0.32/~mol/ 
min .mg protein in OTM. 
3.2. Effect of  3,3"-T2 on OTM cytochrome oxidase activity 
from normal and hypothyroid rats 
The effect of 3,3'-T 2 on intact mitochondria nd OTM cyto- 
chrome oxidase activity is shown in Table 1.3,3'-T2 (10 -6 M) 
had no effect when added to intact mitochondr ia while on 
OTM caused a marked stimulation of cytochrome oxidase ac- 
tivity (+60% and 95% in normal and hypothyroid mitochon- 
dr±a, respectively). 
Table 1 
In vitro effect of 3,3'-T2 on cytochrome oxidase activity of liver 
intact mitochondria and OTM from normal (N) and hypothyroid rats 
(PTU) 
Mitochondrial COX activity 
(natoms O/min.mg protein) 
Controls + 3,3'-T2 (10  -6  M)  
N 
PTU 
OTM 650 ± 63 1040 ± 96* 
(+60%) 
Intact 415 ± 22 435 ± 28 
OTM 541 ± 52 1054 ± 100" 
(+95%) 
Intact 312 ± 7 300 ± 10 
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Fig. 1. Influence of time (A), temperature (B) and pH (C) on specific 
3,3'-T 2 binding. Incubation with 0.85 x 10 -8 M 3,[3'-~25I]T2 was carried 
out for 30 min at 0°C in 1 ml of homogenate atvarious times, temper- 
atures and pH values. Non-specific binding was determined in parallel 
with an excess of 3,3'-T 2 as described in section 2. Assays were per- 
formed in mitochondria after remotion of residual unbound or loosely 
bound 3,3'-T2 by three washes in the presence of 0.5% BSA. Data are 
the mean + S.E.M. of four experiments. 
3.3. 3,3"-T2 binding to mitochondria 
After incubation, liver OTM bound a significant proport ion 
of 3,[3'-115I]T2 added to the incubation medium (6% on aver- 
age). The addit ion of 1000-fold unlabelled 3,3'-T2 caused an 
average displacement of 70% of 3,[3'-~25I]T2 bound. 
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3.4. Characteristics of 3,3"-T 2binding to mitochondria 
In hypothyroid rats specific 3,3'-T2 binding to mitochondria 
occurred rapidly; after 5 min, 30% of binding was reached and 
a maximum was achieved after 60 min (Fig. 1A). The reversibil- 
ity of 3,[3'J25I]T2 binding by isotopic dilution with unlabelled 
3,3'-Tz at equilibrium was of the order of 70%. Specific binding 
was destroyed at 60°C (Fig. IB) while non-specific binding 
increased. Higher values of the specific binding were obtained 
after 60 min at 0°C and at 20°C, while at 37°C the values were 
significantly ower (Fig. 1B). Because of this and as the variabil- 
ity in binding studies is generally lower at 0°C [20] all further 
analyses were carried out at 0°C. Specific 3,3'-T z binding was 
maximal at pH 6.4 (Fig. 1C). No differences were observed in 
the characteristics of the binding between hypothyroid and 
normal mitochondria. 
After having determined the optimal condition for specific 
3,3'-T2 binding all subsequent analyses were performed at 0°C 
and pH 6.4. 
3.5. Saturation analyses 
A series of saturation analyses were performed on OTM at 
pH 6.4 and at 0°C (Fig. 2A). In OTM from PTU treated rats 
0.50 
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Fig. 2. Scatchard plots for 3,3'-T 2binding by the mitochondrial frac- 
tion. A typical Scatchard plot obtained from normal (top panel) and 
hypothyroid (bottom panel) rat liver OTMs is shown. 3,[3'J25I]T2 con- 
centrations ranged from l0 -s to 10 -7 M in both cases. The mitochon- 
drial protein concentration was 1.12 mg/ml and 0.8 mg/ml in hypothy- 
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Fig. 3. Inhibition of specific 3,[3'J25I]T2 binding by increasing concen- 
trations of various analogues added to the incubation medium. Incuba- 
tions were performed intriplicate. Data are the mean +_ S.E.M. of three 
different experiments. For a better representation of the results S.E.M.s 
have been omitted. 
Scatchard plot of values gave a linear negative slope in a con- 
centration range between l0 -8 and 10 -7 M. The mean values for 
the apparent association constant (Ka) and the binding capacity 
were 0.5 x l0 s M -t and 2.4 pmol/mg mitochondrial protein, 
respectively. The same experiment performed on OTM from 
normal animals gave slightly different results. In fact while K, 
was 0.6 x l0 s M -] and did not differ from that measured in 
PTU animals, the binding capacity was higher (5.5 pmol/mg 
mitochondrial protein compared to 2.4 pmol/mg mitochondrial 
protein in hypothyroid animals). 
3.6. Specificity of 3,3"-T 2binding 
The specificity of 3,3'-T2 binding to OTM was examined in 
competition studies using one low concentration f 3,[3'-125I]T2 
and increasing concentration f 3,3'-T2 analogues (Fig. 3). The 
specificity for the tested iodothyronines followed this order: 
3,3'-T2 > 3,5-T2 > rT 3. The other compounds (T3, T4, 3',5'-T2, 
3-T,, 3'-T~, 3,3'-Diac and 3,5-Diac) showed only a small compe- 
tition or none at all. 
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4. Discussion 
Several reports indicate that thyroid hormones have 'long- 
term' and 'short-term' effects on energy metabolism. These 
effects can occur at various levels. Triiodothyronine, the gener- 
ally accepted active form of thyroid hormones, may alter the 
concentration f individual enzymes or may influence, directly 
or indirectly, their kinetic properties (for review see Brand and 
Murphy [21]). Recently, as mentioned before, several reports 
dealing with the action of iodothyronines at the cellular level, 
have shown that two diiodothyronines (3,3'-T2 and 3,5-TE) are 
the thyroid hormone analogues which are most effective at the 
cellular level [1-6]. In previous tudies we hypothesized that T3 
could be responsible for the nuclear and long-term actions of 
thyroid hormones and diiodothyronines for the direct mito- 
chondrial short-term actions [1,2]. This hypothesis presupposes 
the presence of specific binding sites for diiodothyronines in 
mitochondria. In accordance to the hypothesis, in the present 
study we are able to show the presence of specific binding sites 
for 3,3'-T 2 in rat liver mitochondria. 
Both in normal and hypothyroid rats, specific binding to 
OTM occurred fairly rapidly and the reversibility of3,[3'-125I]T2 
binding by isotopic dilution with unlabelled 3,3'-T2 at equilib- 
rium was good and in the order of 70%. The binding of 3,3'-T2 
to OTM decreased at temperature higher than 20°C and was 
completely abolished at 60°C. In hypothyroid and normal ani- 
mals, the apparent association constant (Ka) was 0.5 x l0 s M -~ 
and 0.6 × l08 M -t, respectively, while the capacity was 2.4 
pmol/mg protein and 5.5 pmol/mg protein, respectively. 
The mitochondrial origin of the described sites is highly 
probable regarding the high degree of mitochondrial purifica- 
tion (see enzymatic profile) and the characteristics which differ- 
entiate 3,3'-T2 binding sites from contaminations by other sites 
able to bind other iodothyronines (nuclear and plasmic mem- 
brane binding sites): (1) from the nuclear sites which exhibit a 
different specificity toward analogues [22] and a different affin- 
ity [23]; (2) from plasma membrane binding sites which exhibit 
the highest affinity for T 4 [24]. 
Our data are not in agreement with current concepts with 
regard to biological activity of iodothyronines. In fact, previous 
reports said that diiodothyronines have no physiological po- 
tency in vivo [25,26]. However, in these reports parameters, 
such as growth promotion and antigoitrogenic a tivity, classi- 
cally useful to evaluate T4 or T 3 potency were considered. In 
effect, diiodothyronines ither could influence other parame- 
ters or could not easily enter into the cells when injected in vivo. 
In addition, it has been recently demonstrated that diiodothy- 
ronines, when administered in vivo, stimulate liver cell metabo- 
lism [1,2,5]. 
The other noteworthy point of the present study is that, 
3,3'-T2 directly stimulates COX activity in isolated liver OTM. 
This rapid effect coupled with the presence of specific binding 
sites for 3,3'-T 2 induces us to suggest adirect interaction of this 
compound with COX complex. This hypothesis  supported by 
our recent data demonstrating that diiodothyronines are able 
to stimulate the activity and change the visible spectrum of the 
COX complex isolated from bovine heart mitochondria [27]. 
In particular, we suggest that 3,3'-T2 alters the kinetic prop- 
erties of the COX complex by interaction with non-catalytic 
subunits of COX. Interactions with non catalytic subunits of 
COX (VIa-H) have been recently described for adenine nucleo- 
tides [28,29]. 
In conclusion, the results reported here support our previous 
hypothesis of a direct interaction of 3,3'-T 2 with mitochondria 
and induce us to suggest hat short-term effects of thyroid 
hormones on mitochondrial respiration could be at least partly 
due to the direct interaction of diiodothyronines with mito- 
chondria. 
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